Table 8. Selected muscle strength and physical performance of healthy male adults at baseline and after 8 wk supplementation with FWPS or WPCS
Outcome variables | FWPS group (n=26) | WPCS group (n=22) | p-value1) |
Mean±SD | Mean±SD |
Grip strength Rt |
Baseline | 40.91±4.91 | 40.99±6.49 | 0.915 |
8 wk | 42.25±6.15 | 42.08±5.03 |
Difference2) | –1.34±6.08 | –1.09±4.63 |
p-value3) | 0.272 | 0.281 |
Grip strength Lt |
Baseline | 40.31±5.46 | 39.71±5.34 | 0.186 |
8 wk | 42.57±5.28 | 40.77±4.64 |
Difference2) | –2.26±3.86 | –1.06±3.91 |
p-value3) | 0.006* | 0.216 |
Back muscle strength |
Baseline | 115.94±21.69 | 109.66±18.53 | 0.128 |
8 wk | 125.99±21.28 | 120.60±22.09 |
Difference2) | –10.05±13.96 | –10.94±17.42 |
p-value3) | 0.001* | 0.008* |
Dynamic balance Rt |
Baseline | 101.03±12.67 | 96.79±9.10 | 0.032** |
8 wk | 104.68±16.58 | 97.81±8.13 |
Difference2) | –3.65±7.62 | –1.02±7.50 |
p-value3) | 0.022* | 0.528 |
Dynamic balance Lt |
Baseline | 96.48±10.01 | 92.72±8.38 | 0.032** |
8 wk | 104.28±15.06 | 98.26±9.52 |
Difference2) | –7.80±10.03 | –5.54±8.40 |
p-value3) | 0.001* | 0.006* |
Arm circumference |
Baseline | 30.96±2.19 | 31.65±2.83 | 0.248 |
8 wk | 32.04±2.37 | 32.33±3.09 |
Difference2) | –1.08±1.78 | –0.68±1.60 |
p-value3) | 0.005* | 0.060* |
Thigh girth |
Baseline | 51.12±3.12 | 51.53±3.53 | 0.925 |
8 wk | 53.10±3.29 | 52.45±4.14 |
Difference2) | –1.99±2.67 | –0.92±3.48 |
p-value3) | 0.001* | 0.230 |
Vertical jump |
Baseline | 45.44±8.27 | 44.18±6.46 | 0.316 |
8 wk | 47.02±8.59 | 45.99±8.74 |
Difference2) | –1.58±4.80 | –1.81±5.05 |
p-value3) | 0.107 | 0.108 |
Compared between groups: p-value by two-way ANOVA,
Significant at p<0.05.
Difference between the values of baseline and after 8 wk.
Paired t-test between baseline and 8 wk,
Significant at p<0.05.
FWPS, fermented whey protein supplementation; WPCS, whey protein concentration supplementation; ANOVA, analysis of variance.